Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00716-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Allison A Bauman und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Disease Models, Animal, Rifampin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
The spectinamides are novel, narrow-spectrum semisynthetic analogs of spectinomycin, modified to avoid intrinsic efflux by Mycobacterium tuberculosis . Spectinamides, including lead MBX-4888A (Lee-1810), exhibit promising therapeutic profiles in mice, as single drugs and as partner agents with other anti-tuberculosis antibiotics including rifampin and/or pyrazinamide. Here, we show that MBX-4888A, given by injection with the front-line standard of care regimen, is treatment shortening in multiple murine tuberculosis infection models. The positive treatment responses to MBX-4888A combination therapy in multiple mouse models, including mice exhibiting advanced pulmonary disease, can be attributed to favorable distribution in tissues and lesions, retention in caseum, along with favorable effects with rifampin and pyrazinamide under conditions achieved in necrotic lesions. This study also provides an additional data point regarding the safety and tolerability of spectinamide MBX-4888A in long-term murine efficacy studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA.
- Hackensack Meridian School of Medicine, Center for Discovery and Innovation, Nutley, New Jersey, USA.
- Department of Chemical Biology & Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Microbiotix, Inc., Worcester, Massachusetts, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA.
ORCID-Profile: Jansy P Sarathy, Min Xie, Terry L Bowlin, Bernd Meibohm, Mercedes Gonzalez-Juarrero, Michael A Lyons, Veronique Dartois, Gregory T Robertson
Förderung
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- NIAID NIH HHS
- NIH HHS
- Bill and Melinda Gates Foundation
Zitieren
APA
Bauman, A. A., Sarathy, J. P., Kaya, F., Massoudi, L. M., Scherman, M. S., Hastings, C., Liu, J., Xie, M., Brooks, E. J., Ramey, M. E., Jones, I. L., Benedict, N. D., Maclaughlin, M. R., Miller-Dawson, J. A., Waidyarachchi, S. L., Butler, M. M., Bowlin, T. L., Zimmerman, M. D., Lenaerts, A. J., …, & Robertson, G. T. (2024). Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00716-24
Vancouver
Bauman AA, Sarathy JP, Kaya F, Massoudi LM, Scherman MS, Hastings C, et al. Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00716-24
BibTeX
@article{Bauman2024,
author = {Bauman, Allison A and Sarathy, Jansy P and Kaya, Firat and Massoudi, Lisa M and Scherman, Michael S and Hastings, Courtney and Liu, Jiuyu and Xie, Min and Brooks, Elizabeth J and Ramey, Michelle E and Jones, Isabelle L and Benedict, Noalani D and Maclaughlin, Madelyn R and Miller-Dawson, Jake A and Waidyarachchi, Samanthi L and Butler, Michelle M and Bowlin, Terry L and Zimmerman, Matthew D and Lenaerts, Anne J and Meibohm, Bernd and Gonzalez-Juarrero, Mercedes and Lyons, Michael A and Dartois, Veronique and Lee, Richard E and Robertson, Gregory T},
title = {Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00716-24}
}
EUVIMED